These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059 [TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention. Ganai SA Curr Drug Targets; 2018; 19(6):593-601. PubMed ID: 27231104 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology. Joanna F; van Grunsven LA; Mathieu V; Sarah S; Sarah D; Karin V; Tamara V; Vera R J Cell Mol Med; 2009 Sep; 13(9B):2990-3005. PubMed ID: 19583816 [TBL] [Abstract][Full Text] [Related]
18. The emerging roles of HDACs and their therapeutic implications in cancer. Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Bai G; Wei D; Zou S; Ren K; Dubner R Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]